Nuvation Bio Announces New Data from Pivotal Clinical Studies of IBTROZI in Advanced ROS1-Positive Non-Small Cell Lung Cancer at 2025 World Conference on Lung Cancer Nanotech Investing
Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio Nanotech Investing
Anixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference Nanotech Investing
dynaCERT Receives a Purchase Order from Hydrofuel for 100 HydraGEN Units Destined for Mexico Cleantech Investing
